Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,792
New position
Shares Held
7
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#830
of 870 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MANNING & NAPIER ADVISORS LLC holds $28,794,500 across 9 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,425,546 | $22,637,670 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
206,900 | $3,316,607 | |
| 3 | HLN |
Haleon plc
|
300,561 | $2,804,234 | |
| 4 | ZTS |
Zoetis Inc.
|
239 | $17,174 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
55 | $9,269 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
7 | $3,792 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
86 | $2,913 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
38 | $1,767 |
All Filings in UTHR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,792 | 7 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||